Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2011, Article ID 402127, 6 pages
http://dx.doi.org/10.1155/2011/402127
Case Report

Asymptomatic Primary Fallopian Tube Cancer: An Unusual Cause of Axillary Lymphadenopathy

1Department of Surgery, School of Medicine, Clinical Science Institute, National University of Ireland, Galway, Ireland
2Department of Pathology, National University of Ireland, Galway, Ireland
3Department of Radiology, National University of Ireland, Galway, Ireland
4Division of Obstetrics and Gynaecology, National University of Ireland, Galway, Ireland

Received 10 August 2011; Accepted 13 September 2011

Academic Editors: J.-H. Nam and E. C. Nwosu

Copyright © 2011 N. A. Healy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. D. Schwab, H. Burger, M. Isenschmid, A. Kuhn, M. D. Mueller, and A. R. Günthert, “Suspicious axillary lymph nodes in patients with unremarkable imaging of the breast,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 150, no. 1, pp. 88–91, 2010. View at Publisher · View at Google Scholar · View at PubMed
  2. S. G. Orel, S. P. Weinstein, M. D. Schnall et al., “Breast MR imaging in patients with axillary node metastases and unknown primary malignancy,” Radiology, vol. 212, no. 2, pp. 543–549, 1999. View at Google Scholar · View at Scopus
  3. T. C. Kwee, S. Basu, G. Cheng, and A. Alavi, “FDG PET/CT in carcinoma of unknown primary,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 3, pp. 635–644, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. S. L. Stewart, J. M. Wike, S. L. Foster, and F. Michaud, “The incidence of primary fallopian tube cancer in the United States,” Gynecologic Oncology, vol. 107, no. 3, pp. 392–397, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. A. Gadducci, F. Landoni, E. Sartori et al., “Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a Cooperation Task Force (CTF) study,” Gynecologic Oncology, vol. 81, no. 2, pp. 150–159, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. C. Kosary and E. L. Trimble, “Treatment and survival for women with fallopian tube carcinoma: a population-based study,” Gynecologic Oncology, vol. 86, no. 2, pp. 190–191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. E. H. McMurray, A. J. Jacobs, and C. A. Perez, “Carcinoma of the fallopian tube. Management and sites of failure,” Cancer, vol. 58, no. 9, pp. 2070–2075, 1986. View at Google Scholar · View at Scopus
  8. M. Al-Hussaini, A. Stockman, H. Foster, and W. G. McCluggage, “WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma,” Histopathology, vol. 44, no. 2, pp. 109–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. R. Wick, T. J. Lillemoe, G. T. Copland, P. E. Swanson, J. C. Manivel, and D. T. Kiang, “Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin,” Human Pathology, vol. 20, no. 3, pp. 281–287, 1989. View at Google Scholar · View at Scopus
  10. M. Dietel, H. Arps, and R. Klapdor, “Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera,” Journal of Cancer Research and Clinical Oncology, vol. 111, no. 3, pp. 257–265, 1986. View at Google Scholar · View at Scopus
  11. I. A. Koelma, M. Nap, C. J. Rodenburg, and G. J. Fleuren, “The value of tumour marker CA 125 in surgical pathology,” Histopathology, vol. 11, no. 3, pp. 287–294, 1987. View at Google Scholar · View at Scopus
  12. S. E. Kabawat, R. C. Bast, and W. R. Welch, “Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrial, and clear cell types,” American Journal of Clinical Pathology, vol. 79, no. 1, pp. 98–104, 1983. View at Google Scholar · View at Scopus
  13. M. M. Vaughan, B. D. Evans, J. Baranyai, and M. J. Weitzer, “Survival of patients with primary fallopian tube carcinoma,” International Journal of Gynecological Cancer, vol. 8, no. 1, pp. 16–22, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. T. V. Ajithkumar, A. L. Minimole, M. M. John, and O. S. Ashokkumar, “Primary fallopian tube carcinoma,” Obstetrical and Gynecological Survey, vol. 60, no. 4, pp. 247–252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Pectasides, E. Pectasides, and T. Economopoulos, “Fallopian tube carcinoma: a review,” Oncologist, vol. 11, no. 8, pp. 902–912, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. M. L. Gemignani, M. L. Hensley, R. Cohen, E. Venkatraman, P. E. Saigo, and R. R. Barakat, “Paclitaxel-based chemotherapy in carcinoma of the fallopian tube,” Gynecologic Oncology, vol. 80, no. 1, pp. 16–20, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. E. D. Euscher, E. G. Silva, M. T. Deavers, E. Elishaev, D. M. Gershenson, and A. Malpica, “Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy,” American Journal of Surgical Pathology, vol. 28, no. 9, pp. 1217–1223, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Alvarado-Cabrero, R. H. Young, E. C. Vamvakas, and R. E. Scully, “Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factors,” Gynecologic Oncology, vol. 72, no. 3, pp. 367–379, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. S. Aziz et al., “A genetic epidemiological study of carcinoma of the Fallopian tube,” Gynecologic Oncology, vol. 80, no. 3, pp. 341–345, 2001. View at Google Scholar
  20. D. A. Levine, P. A. Argenta, C. J. Yee et al., “Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations,” Journal of Clinical Oncology, vol. 21, no. 22, pp. 4222–4227, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. R. P. Zweemer, P. J. Van Diest, R. H. M. Verheijen et al., “Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations,” Gynecologic Oncology, vol. 76, no. 1, pp. 45–50, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. A. C. Rosen, C. Ausch, M. Klein et al., “p53 expression in fallopian tube carcinomas,” Cancer Letters, vol. 156, no. 1, pp. 1–7, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Zheng, C. J. Sung, P. Cao et al., “Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube,” Gynecologic Oncology, vol. 64, no. 1, pp. 38–48, 1997. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus